GlassScriptPhysician profile
Raymond B Rawson
NPI 1164457008
$83,072.79
in general payments reported to CMS, 2019-2025
8 companies · $21K in 2025
The $21K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,705 · 2020: $221 · 2021: $5,377 · 2022: $10K · 2023: $17K · 2024: $27K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Travel and Lodging: $5,610 · Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,555.50 |
| Travel and Lodging | $5,610.42 |
| Food and Beverage | $1,143.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovasis INC | $74,246.92 | 2021-2025 | |
| Boston Scientific Corporation | $8,028.72 | 2019-2025 | General - Pain Management, Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Spine Wave, INC. | $349.13 | 2019-2021 | |
| Abbott Laboratories | $195.46 | 2019-2024 | Proclaim |
| Spineology INC. | $120.00 | 2025 | |
| Nevro Corp. | $104.67 | 2024 | Senza |
| Djo, LLC | $16.39 | 2021 | |
| Stryker Corporation | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Rawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.